Dechra Acquires Rights To Synthetic Reproductive Hormone Sucromate Equine

Dechra is pleased to announce the acquisition of Sucromate Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C. This acquisition expands Dechra's equine portfolio in the reproductive category.

Mike Eldred, President of Dechra North America, stated, “Sucromate Equine is a sterile, synthetic gonadotropin-releasing hormone (GnRH) analog suspension that veterinarians have used and relied on for their breeding operations. Sucromate Equine expands Dechra's reproductive portfolio and complements our existing product offering.”

[Story Continues Below]

Sucromate Equine (deslorelin acetate) sterile suspension should be used exclusively by veterinarians.

The product is now available for veterinarians to purchase through select veterinary distributors.

Read more here.

The post Dechra Acquires Rights To Synthetic Reproductive Hormone Sucromate Equine appeared first on Horse Racing News | Paulick Report.

Source of original post

Picking a Longines Breeders’ Cup Turf Winner Using History as a Guide

Every year, the Breeders’ Cup attracts a strong contingent of international raiders to challenge North America’s best horses in a series of lucrative races. And among the 14 Breeders’ Cup events, none of the World Championships races attracts a stronger international presence on a year-to-year basis than the $4 million Longines Breeders’ Cup Turf.

Read More...

Source of original post

Verified by MonsterInsights